These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7450164)

  • 1. Circulating forms of glucagon and related peptides in normal subjects and uraemic patients.
    Flanagan RW; Murphy RF; Buchanan KD
    Biochem Soc Trans; 1980 Aug; 8(4):426-7. PubMed ID: 7450164
    [No Abstract]   [Full Text] [Related]  

  • 2. Medium-sized peptides in the blood of patients with uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1983; 33(4):232-7. PubMed ID: 6843753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All products of proglucagon are elevated in plasma from uremic patients.
    Orskov C; Andreasen J; Holst JJ
    J Clin Endocrinol Metab; 1992 Feb; 74(2):379-84. PubMed ID: 1730817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglucagonemia in uremia: reversal by renal transplantation.
    Bilbrey GL; Faloona GR; White MG; Atkins C; Hull AR; Knochel JP
    Ann Intern Med; 1975 Apr; 82(4):525-8. PubMed ID: 1091189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte glycolysis in uraemia: cynamic balance caused by the opposite action of various factors.
    Gajdos M; Dzúrik R
    Int Urol Nephrol; 1974; 5(3):331-6. PubMed ID: 4829138
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma C-peptide in uraemic patients.
    Regeur L; Faber OK; Binder C
    Scand J Clin Lab Invest; 1978 Dec; 38(8):771-5. PubMed ID: 741207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High circulating concentrations of glucagon in non-anaemic uraemic patients.
    McEvoy J; McCarroll AM
    Br Med J; 1978 Jul; 2(6129):17-8. PubMed ID: 678785
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
    Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
    J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on hyperglucagonemia in renal failure].
    Oka H
    Fukuoka Igaku Zasshi; 1987 Jul; 78(7):402-13. PubMed ID: 3679060
    [No Abstract]   [Full Text] [Related]  

  • 10. A uremic peptide containing polyamine: formation and possible role in uremic hypertriglyceridemia.
    Lutz W
    Physiol Chem Phys; 1980; 12(5):451-6. PubMed ID: 7010392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics.
    Hanicki Z; Sarnecka-Keller M; Klein A; Slizowska K
    Clin Chim Acta; 1974 Jul; 54(1):47-54. PubMed ID: 4847123
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
    Rinaudo JB; Gallice P; Crevat A; Saingra S; Murisasco A
    Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non diffusible toxic polypeptides in uraemic sera: a new group of uraemic toxins.
    Gróf J; Menyhárt J
    Acta Chir Acad Sci Hung; 1977; 18(3):283-7. PubMed ID: 605725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucose utilization in rat diaphragm by the urinary peptides fractionated by high-voltage electrophoresis.
    Dzúrik R; Adam J; Moscovic F
    Int Urol Nephrol; 1973 Apr; 5(2):217-21. PubMed ID: 4774526
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of N-monoacetylcystine in uraemic plasma.
    Gejyo F; Ito G; Kinoshita Y
    Clin Sci (Lond); 1981 Mar; 60(3):331-4. PubMed ID: 7237945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating types of human glucagon (author's transl)].
    Valverde I
    MMW Munch Med Wochenschr; 1978 Mar; 120(12):407-9. PubMed ID: 306029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric monitoring of albumin in uremia.
    Thornalley PJ; Argirova M; Ahmed N; Mann VM; Argirov O; Dawnay A
    Kidney Int; 2000 Nov; 58(5):2228-34. PubMed ID: 11044246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia of chronic renal failure; effect of uraemic serum on proliferation and differentiation of stem cells.
    Agarwal S; Mathur M; Deo MG; Sood SK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):371-6. PubMed ID: 548489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.